ALPMF saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on December 16, 2024. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 48 instances where the indicator turned negative. In of the 48 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .
The Momentum Indicator moved below the 0 level on December 10, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on ALPMF as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
ALPMF moved below its 50-day moving average on December 05, 2024 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALPMF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for ALPMF entered a downward trend on December 05, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ALPMF's RSI Oscillator exited the oversold zone, of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
ALPMF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.526) is normal, around the industry mean (5.632). P/E Ratio (39.216) is within average values for comparable stocks, (48.974). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.004). Dividend Yield (0.029) settles around the average of (0.164) among similar stocks. P/S Ratio (2.548) is also within normal values, averaging (3.643).
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ALPMF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALPMF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock worse than average.
Industry PharmaceuticalsMajor
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FFLS | 24.10 | 0.03 | +0.11% |
Future Fund Long/Short ETF | |||
RNEW | 26.35 | N/A | N/A |
VanEck® Green Infrastructure ETF | |||
FXG | 66.56 | -0.30 | -0.45% |
First Trust Cnsmr Staples AlphaDEX® ETF | |||
PHDG | 38.90 | -0.28 | -0.71% |
Invesco S&P 500® Downside Hedged ETF | |||
BULZ | 198.97 | -3.00 | -1.49% |
MicroSectors™ Slct FANG Inn 3X Lvgd ETNs |
A.I.dvisor indicates that over the last year, ALPMF has been loosely correlated with ALPMY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ALPMF jumps, then ALPMY could also see price increases.
Ticker / NAME | Correlation To ALPMF | 1D Price Change % | ||
---|---|---|---|---|
ALPMF | 100% | N/A | ||
ALPMY - ALPMF | 38% Loosely correlated | -0.30% | ||
JNJ - ALPMF | 13% Poorly correlated | +1.78% | ||
GRFS - ALPMF | 10% Poorly correlated | +5.64% | ||
AZNCF - ALPMF | 8% Poorly correlated | +1.29% | ||
ABBV - ALPMF | 5% Poorly correlated | +2.18% | ||
More |